Anti-phospho-Akt antibodies
US9029512B2 · kind B2 · utility
0Cited by
8References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 13, 2009 |
| Grant date | May 12, 2015 |
| Priority date | — |
| Expiry date | Jan 2, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91205
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies that immunospecifically bind to phospho-Akt and certain p-Akt substrates. The invention encompasses human and humanized forms of the antibodies and their use in treating cancers and other proliferative disorders. The invention also relates to p-Akt-derived peptides useful for preparing the antibodies. Methods and compositions for detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other proliferative disorders using the present antibodies also are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.